About the journal
Forum of Clinical Oncology is an open-access journal published by Sciendo in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Sciendo
- ISSN
- 1792-362X · 1792-345X
- Country
- Poland
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 144
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://reference-global.com/journal/FCO
Index listings
- DOAJ · 2015-05-29
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
144
Most recent article
14 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
163
Last recorded publication year
2025
h-index
7
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-07-24
- Added to DOAJ
- 2015-05-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- Portico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 9%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- FCOQuarterly official publication of Hellenic Society of Medical Oncology
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Show all subjects (50)
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Pancreatic and Hepatic Oncology Research
- Breast Cancer Treatment Studies
- Sarcoma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Neuroblastoma Research and Treatments
- Advances in Oncology and Radiotherapy
- Breast Cancer Treatment Studies
- Advances in Oncology and Radiotherapy
- Neuroblastoma Research and Treatments
- Head and Neck Cancer Studies
- Sarcoma Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Economic and Financial Impacts of Cancer
- Colorectal Cancer Surgical Treatments
- Palliative Care and End-of-Life Issues
- Palliative Care and End-of-Life Issues
- Economic and Financial Impacts of Cancer
- Colorectal and Anal Carcinomas
- Thyroid Cancer Diagnosis and Treatment
- Colorectal and Anal Carcinomas
- Cancer Risks and Factors
- Genetic factors in colorectal cancer
- Bone health and treatments
- HER2/EGFR in Cancer Research
- Thyroid Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- RNA modifications and cancer
- RNA modifications and cancer
- Bone health and treatments
- Genetic factors in colorectal cancer
- HER2/EGFR in Cancer Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Keywords (DOAJ)
- oncology
- hematology
- cancer
- biomarkers
- pharmacoeconomics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ